Invest in the future of drug optimization

INVEST IN THE FUTURE OF DRUG OPTIMIZATION

We can make a difference.

Virpax Pharmaceuticals is collaborating with the best research and development minds in the pharmaceutical industry. We are collaborating with these global drug development leaders, so we may improve how non-addictive pain medications and CNS disorder medications are delivered.

As part of our ongoing non-dilutive funding strategy, Virpax will pursue US and ex-US sublicensing and co-development opportunities with strategic partners in human and animal healthcare. We will also continue to seek government and military grants and cooperation agreements.

Partner with us as we develop and seek global approval for our next generation of non-addictive pain and CNS disorder product candidates.

VRPX Tower on stock exchange

Investor News

View all

Presentations

 

 

Email alerts

BUSINESS INQUIRIES

Virpax Pharmaceuticals, Inc.
1055 Westlakes Drive, Suite 300
Berwyn, PA 19312
610.727.4597
info@virpaxpharma.com

INVESTOR INQUIRIES

Betsy Brod
Affinity Growth Advisors
betsy.brod@affinitygrowth.com

MEDIA INQUIRIES

Public Relations
Virpax Pharmaceuticals, Inc.
pr@virpaxpharma.com